Cumberland Pharmaceuticals (CPIX) Net Cash Flow (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Net Cash Flow across 17 years of filings, most recently posting -$437448.0 for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$437448.0, up 84.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 19.22% YoY), and the FY2025 annual result was -$6.5 million, down 1723.94% from the prior year.
• Net Cash Flow came in at -$437448.0 for Q1 2026 at Cumberland Pharmaceuticals, up from -$3.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $1.9 million in Q2 2023 to a low of -$9.8 million in Q1 2022.
• The 5-year median for Net Cash Flow is $128308.0 (2024), against an average of -$943151.2.
• Across the five-year window, Net Cash Flow sank 2895.59% in 2022 and surged 368.02% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Net Cash Flow stood at $216432.0 in 2022, then slumped by 186.1% to -$186341.0 in 2023, then soared by 368.02% to $499430.0 in 2024, then plunged by 851.27% to -$3.8 million in 2025, then jumped by 88.34% to -$437448.0 in 2026.
• The last three Net Cash Flow figures came in at -$437448.0 (Q1 2026), -$3.8 million (Q4 2025), and -$890536.0 (Q3 2025), per Business Quant data.